Getinge AB (publ) (GETI-B.ST)
SEK 174.85
(2.01%)
SEK 174.85
(2.01%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 3.9 Billion SEK | -22.42% |
| 2022 | 5.03 Billion SEK | 43.95% |
| 2021 | 3.49 Billion SEK | -54.53% |
| 2020 | 7.68 Billion SEK | 8.76% |
| 2019 | 7.06 Billion SEK | -4.2% |
| 2018 | 7.37 Billion SEK | 48.69% |
| 2017 | 4.96 Billion SEK | -68.82% |
| 2016 | 15.91 Billion SEK | -0.57% |
| 2015 | 16 Billion SEK | 11.32% |
| 2014 | 14.37 Billion SEK | 5.99% |
| 2013 | 13.56 Billion SEK | 3.06% |
| 2012 | 13.16 Billion SEK | -12.95% |
| 2011 | 15.12 Billion SEK | 32.51% |
| 2010 | 11.41 Billion SEK | -28.85% |
| 2009 | 16.03 Billion SEK | 21.95% |
| 2008 | 13.15 Billion SEK | 43.78% |
| 2007 | 9.14 Billion SEK | 108.62% |
| 2006 | 4.38 Billion SEK | 6.83% |
| 2005 | 4.1 Billion SEK | 11.09% |
| 2004 | 3.69 Billion SEK | 13.83% |
| 2003 | 3.24 Billion SEK | 34.36% |
| 2002 | 2.41 Billion SEK | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 3.74 Billion SEK | -4.07% |
| 2024 Q3 | 5.91 Billion SEK | 106.35% |
| 2024 Q2 | 2.86 Billion SEK | -23.42% |
| 2023 Q3 | 6.81 Billion SEK | -1.15% |
| 2023 Q1 | 5.81 Billion SEK | 15.6% |
| 2023 Q2 | 6.89 Billion SEK | 18.52% |
| 2023 FY | 3.9 Billion SEK | -22.42% |
| 2023 Q4 | 3.9 Billion SEK | -42.72% |
| 2022 Q2 | 5 Billion SEK | 32.4% |
| 2022 Q3 | 5.49 Billion SEK | 9.94% |
| 2022 FY | 5.03 Billion SEK | 43.95% |
| 2022 Q4 | 5.03 Billion SEK | -8.51% |
| 2022 Q1 | 3.77 Billion SEK | 8.1% |
| 2021 Q1 | 5.88 Billion SEK | -23.44% |
| 2021 Q4 | 3.49 Billion SEK | -20.11% |
| 2021 Q3 | 4.37 Billion SEK | -12.38% |
| 2021 FY | 3.49 Billion SEK | -54.53% |
| 2021 Q2 | 4.99 Billion SEK | -15.16% |
| 2020 Q2 | 13.28 Billion SEK | 19.53% |
| 2020 Q4 | 7.68 Billion SEK | -36.13% |
| 2020 FY | 7.68 Billion SEK | 8.76% |
| 2020 Q1 | 11.11 Billion SEK | 57.22% |
| 2020 Q3 | 12.03 Billion SEK | -9.38% |
| 2019 Q4 | 7.06 Billion SEK | -39.24% |
| 2019 FY | 7.06 Billion SEK | -4.2% |
| 2019 Q3 | 11.63 Billion SEK | -0.54% |
| 2019 Q2 | 11.69 Billion SEK | 0.03% |
| 2019 Q1 | 11.69 Billion SEK | 58.46% |
| 2018 Q2 | 11.56 Billion SEK | 5.63% |
| 2018 Q3 | 10.73 Billion SEK | -7.18% |
| 2018 FY | 7.37 Billion SEK | 48.69% |
| 2018 Q4 | 7.37 Billion SEK | -31.25% |
| 2018 Q1 | 10.94 Billion SEK | 120.6% |
| 2017 Q1 | 21.72 Billion SEK | 36.53% |
| 2017 Q4 | 4.96 Billion SEK | -69.27% |
| 2017 Q3 | 16.14 Billion SEK | -22.73% |
| 2017 Q2 | 20.89 Billion SEK | -3.82% |
| 2017 FY | 4.96 Billion SEK | -68.82% |
| 2016 Q4 | 15.91 Billion SEK | -27.43% |
| 2016 Q3 | 21.92 Billion SEK | -0.64% |
| 2016 Q1 | 21.73 Billion SEK | 35.76% |
| 2016 FY | 15.91 Billion SEK | -0.57% |
| 2016 Q2 | 22.07 Billion SEK | 1.57% |
| 2015 Q1 | 22.27 Billion SEK | 54.94% |
| 2015 FY | 16 Billion SEK | 11.32% |
| 2015 Q4 | 16 Billion SEK | -26.91% |
| 2015 Q3 | 21.89 Billion SEK | 1.41% |
| 2015 Q2 | 21.59 Billion SEK | -3.07% |
| 2014 Q2 | 19.09 Billion SEK | 17.83% |
| 2014 Q1 | 16.2 Billion SEK | 19.45% |
| 2014 FY | 14.37 Billion SEK | 5.99% |
| 2014 Q4 | 14.37 Billion SEK | -28.1% |
| 2014 Q3 | 19.99 Billion SEK | 4.73% |
| 2013 Q3 | 16.22 Billion SEK | -5.63% |
| 2013 Q2 | 17.19 Billion SEK | 0.0% |
| 2013 Q1 | - SEK | -100.0% |
| 2013 FY | 13.56 Billion SEK | 3.06% |
| 2013 Q4 | 13.56 Billion SEK | -16.39% |
| 2012 Q1 | - SEK | -100.0% |
| 2012 Q2 | - SEK | 0.0% |
| 2012 Q3 | - SEK | 0.0% |
| 2012 FY | 13.16 Billion SEK | -12.95% |
| 2012 Q4 | 13.16 Billion SEK | 0.0% |
| 2011 Q1 | - SEK | -100.0% |
| 2011 Q4 | 15.12 Billion SEK | 0.0% |
| 2011 FY | 15.12 Billion SEK | 32.51% |
| 2011 Q3 | - SEK | 0.0% |
| 2011 Q2 | - SEK | 0.0% |
| 2010 Q1 | - SEK | -100.0% |
| 2010 FY | 11.41 Billion SEK | -28.85% |
| 2010 Q4 | 11.41 Billion SEK | 0.0% |
| 2010 Q3 | - SEK | 0.0% |
| 2010 Q2 | - SEK | 0.0% |
| 2009 Q4 | 16.03 Billion SEK | 0.0% |
| 2009 FY | 16.03 Billion SEK | 21.95% |
| 2008 FY | 13.15 Billion SEK | 43.78% |
| 2007 FY | 9.14 Billion SEK | 108.62% |
| 2006 FY | 4.38 Billion SEK | 6.83% |
| 2005 FY | 4.1 Billion SEK | 11.09% |
| 2004 FY | 3.69 Billion SEK | 13.83% |
| 2003 FY | 3.24 Billion SEK | 34.36% |
| 2002 FY | 2.41 Billion SEK | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Acarix AB (publ) | - SEK | -Infinity% |
| ADDvise Group AB (publ) | 1.45 Billion SEK | -167.916% |
| ADDvise Group AB (publ) | 1.45 Billion SEK | -167.916% |
| Arcoma AB | 1.92 Million SEK | -202442.813% |
| Bactiguard Holding AB (publ) | 42.3 Million SEK | -9125.642% |
| BICO Group AB (publ) | 1.75 Billion SEK | -122.342% |
| Boule Diagnostics AB (publ) | 57.7 Million SEK | -6664.298% |
| CellaVision AB (publ) | 28.66 Million SEK | -13516.383% |
| Clinical Laserthermia Systems AB (publ) | 223 Thousand SEK | -1750124.215% |
| Chordate Medical Holding AB (publ) | - SEK | -Infinity% |
| C-Rad AB (publ) | 1.75 Million SEK | -222546.891% |
| Duearity AB (publ) | 2.94 Million SEK | -132655.102% |
| Dignitana AB (publ) | 6.07 Million SEK | -64125.769% |
| Episurf Medical AB (publ) | 2.3 Million SEK | -169595.652% |
| Scandinavian Real Heart AB (Publ) | 6.35 Million SEK | -61336.316% |
| Iconovo AB (publ) | 4.9 Million SEK | -79441.087% |
| Integrum AB (publ) | 4.84 Million SEK | -80464.725% |
| Luxbright AB (publ) | 206.02 Thousand SEK | -1894339.483% |
| Mentice AB (publ) | 2.14 Million SEK | -181942.91% |
| OssDsign AB (publ) | 214 Thousand SEK | -1823731.776% |
| Paxman AB (publ) | 2.53 Million SEK | -154046.919% |
| Promimic AB (publ) | - SEK | -Infinity% |
| Qlife Holding AB (publ) | 3 Million SEK | -129826.764% |
| SciBase Holding AB (publ) | 4.17 Million SEK | -93295.549% |
| ScandiDos AB (publ) | - SEK | -Infinity% |
| Sectra AB (publ) | 19.2 Million SEK | -20223.891% |
| Sedana Medical AB (publ) | 1.01 Million SEK | -385571.937% |
| Senzime AB (publ) | 8.57 Million SEK | -45400.117% |
| SpectraCure AB (publ) | 4.39 Million SEK | -88665.067% |
| Stille AB | 38.06 Million SEK | -10153.244% |
| Vitrolife AB (publ) | 1.87 Billion SEK | -108.16% |
| Xvivo Perfusion AB (publ) | 21.16 Million SEK | -18337.338% |